TULSA, Okla.--(BUSINESS WIRE)--Cancer Treatment Centers of America® (CTCA) in Tulsa recently announced the addition of Beomjune B. Kim, DMD, MD, FACS, an experienced head and neck surgeon, who is board certified in head and neck oncology and microvascular reconstructive surgery as well as oral and maxillofacial surgery by the American Board of Oral and Maxillofacial Surgery.
“We are thrilled to welcome Dr. Kim to our team,” said Jay Foley, president and CEO of CTCA Tulsa. “He is a results-driven individual with a passion for innovative cancer care. Dr. Kim’s expertise will provide our patients with excellent options relating to head and neck oncology and maxillofacial reconstruction.”
Dr. Kim earned a medical degree from the University of Maryland School of Medicine in Baltimore, MD, and a dentistry degree from the University of Pennsylvania School of Dentistry in Philadelphia, PA. He completed an internship in oral and maxillofacial surgery from the Hospital of the University of Pennsylvania and an oral and maxillofacial surgery residency at the University Maryland Medical Center. To further his training, Dr. Kim completed a head and neck oncology and microvascular reconstructive surgery fellowship at the Louisiana State University Health Sciences Center in Shreveport, LA.
Prior to joining CTCA, Dr. Kim served as an assistant professor in the Department of Oral and Maxillofacial Surgery at Louisiana State University and has since co-authored numerous clinical research publications. Dr. Kim is also a fellow of the American Association of Oral and Maxillofacial Surgeons, a fellow of the American Academy of CranioMaxilloFacial Surgeons, and an editorial board member of Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America Global, Inc. (CTCA) is a comprehensive cancer care network of hospitals and outpatient care centers in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Specializing in the treatment of adult cancer patients, CTCA® offers an integrative approach to care that combines surgery, radiation, chemotherapy, and immunotherapy with advancements in precision cancer treatment and supportive therapies designed to manage side effects and enhance quality of life both during and after treatment. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter for more information.
